|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2002-3-28
|
|
pubmed:abstractText |
To evaluate the safety and efficacy of 2 dosages of cevimeline for the treatment of xerostomia and keratoconjunctivitis sicca in patients with Sjögren's syndrome.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
0004-3591
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
46
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
748-54
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:11920411-Adult,
pubmed-meshheading:11920411-Aged,
pubmed-meshheading:11920411-Dose-Response Relationship, Drug,
pubmed-meshheading:11920411-Double-Blind Method,
pubmed-meshheading:11920411-Female,
pubmed-meshheading:11920411-Humans,
pubmed-meshheading:11920411-Keratoconjunctivitis Sicca,
pubmed-meshheading:11920411-Male,
pubmed-meshheading:11920411-Middle Aged,
pubmed-meshheading:11920411-Muscarinic Agonists,
pubmed-meshheading:11920411-Placebos,
pubmed-meshheading:11920411-Quinuclidines,
pubmed-meshheading:11920411-Safety,
pubmed-meshheading:11920411-Saliva,
pubmed-meshheading:11920411-Sjogren's Syndrome,
pubmed-meshheading:11920411-Tears,
pubmed-meshheading:11920411-Thiophenes,
pubmed-meshheading:11920411-Xerostomia
|
|
pubmed:year |
2002
|
|
pubmed:articleTitle |
A double-blind, randomized, placebo-controlled study of cevimeline in Sjögren's syndrome patients with xerostomia and keratoconjunctivitis sicca.
|
|
pubmed:affiliation |
Baylor University Medical Center and Arthritis Centers of Texas, Dallas 75246, USA. trone6534@aol.com
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
